PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of teriflunomide tablets to its current portfolio.
PISCATAWAY, N.J. – Camber Pharmaceuticals announced the addition of teriflunomide tablets to its current portfolio.
Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Teriflunomide tablets are available in 7 and 14 mg strengths and supplied in 30 count bottles.
Chlorzoxazone tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
2025 State of Drug Access report from RazorMetrics reveals new insights into consumer feelings about pharmacy access.
The updated UL is part of CRN’s ongoing release of revised nutrient safety chapters from its Vitamin and Mineral Safety (4th edition).
Prescription medications have seen the highest inflation compared to other medical goods, like nonprescription medications and medical equipment.
Chlorzoxazone tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
2025 State of Drug Access report from RazorMetrics reveals new insights into consumer feelings about pharmacy access.
The updated UL is part of CRN’s ongoing release of revised nutrient safety chapters from its Vitamin and Mineral Safety (4th edition).
Prescription medications have seen the highest inflation compared to other medical goods, like nonprescription medications and medical equipment.
